The current debate in cardiology centers on the use of drug-eluting balloons (DEBs) vs drug-eluting stents (DESs) in de novo lesions. However, to reach this conclusion, it must be shown that the ...
No trial has tested starting all four HFrEF drugs at once. What the speed evidence actually supports, where guidelines split, and how to close the implementation gap.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results